KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC

磷酸戊糖途径 脆弱性(计算) 癌症研究 细胞生物学 化学 医学 内科学 生物 计算机科学 新陈代谢 糖酵解 计算机安全
作者
Xiangyan Jiang,Tao Wang,Bin Xia Zhao,Haonan Sun,Yuman Dong,Yong Ma,Zhigang Li,Yuxia Wu,Keshen Wang,Xiaoying Guan,Bo Long,Long Qin,Wengui Shi,Lei Shi,Qichen He,Wenbo Liu,Mingdou Li,Lixia Xiao,Chenhe Zhou,Hui Sun
出处
期刊:Cell reports medicine [Elsevier BV]
卷期号:6 (2): 101966-101966 被引量:26
标识
DOI:10.1016/j.xcrm.2025.101966
摘要

The KRAS G12D inhibitor MRTX1133 shows the potential to revolutionize the treatment paradigm for pancreatic ductal adenocarcinoma (PDAC), yet presents challenges. Our findings indicate that KRAS G12D remodels a pentose phosphate pathway (PPP)-dominant central carbon metabolism pattern, facilitating malignant progression and resistance to MRTX1133 in PDAC. Mechanistically, KRAS G12D drives excessive degradation of p53 and glucose-6-phosphate dehydrogenase (G6PD)-mediated PPP reprogramming through retinoblastoma (Rb)/E2F1/p53 axis-regulated feedback loops that amplify ubiquitin-conjugating enzyme E2T (UBE2T) transcription. Genetic ablation or pharmacological inhibition of UBE2T significantly suppresses PDAC progression and potentiates MRTX1133 efficacy. Leveraging structure advantages of the UBE2T inhibitor pentagalloylglucose (PGG), we develop a self-assembling nano co-delivery system with F-127, PGG, and MRTX1133. This system enhances the efficacy of PGG and MRTX1133, achieving durable remissions (85% overall response rate) and long-term survival (100% progression-free survival) in patient-derived xenografts and spontaneous PDAC mice. This study reveals the role of KRAS G12D -preferred PPP reprogramming in MRTX1133 resistance and proposes a potentially therapeutic strategy for KRAS G12D -mutated PDAC. • KRAS G12D -driven PPP remodeling promotes PDAC progression and MRTX1133 resistance • KRAS G12D promotes PPP reprogramming via Rb/E2F1/UBE2T/p53 feedback loops • UBE2T confers progression and resistance to MRTX1133 in KRAS G12D -mutated PDAC • Nano co-delivery of the UBE2T inhibitor and MRTX1133 achieves durable remissions Jiang et al. uncover that KRAS G12D drives a pentose phosphate pathway-dominant reprogramming of central carbon metabolism through UBE2T-mediated feedback mechanisms. They develop a nano co-delivery system combining F-127, the UBE2T inhibitor PGG, and the KRAS G12D inhibitor MRTX1133, inducing significant tumor regression and durable therapeutic responses in KRAS G12D -mutant PDAC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DW发布了新的文献求助10
刚刚
刚刚
刚刚
灞波儿奔的应助被Ted采纳,获得10
刚刚
Ava的应助被zz采纳,获得10
1秒前
1秒前
2秒前
rapamycin发布了新的文献求助10
2秒前
2秒前
dipa发布了新的文献求助10
3秒前
3秒前
3秒前
主任完成签到 ,获得积分10
3秒前
芥菜种子完成签到 ,获得积分10
4秒前
张美超发布了新的文献求助10
4秒前
lan完成签到,获得积分10
4秒前
郑睿涛完成签到,获得积分10
5秒前
ojoijn发布了新的文献求助10
5秒前
404发布了新的文献求助10
5秒前
qizhang完成签到,获得积分10
5秒前
CodeCraft的应助被游标卡尺采纳,获得10
5秒前
姜雨杭发布了新的文献求助10
5秒前
长生发布了新的文献求助10
6秒前
6秒前
6秒前
迪迪子完成签到,获得积分10
6秒前
甜美冰香发布了新的文献求助10
6秒前
7秒前
7秒前
江北小赵发布了新的文献求助10
7秒前
zhangyaoyang发布了新的文献求助10
7秒前
三笠发布了新的文献求助10
8秒前
8秒前
n11发布了新的文献求助10
8秒前
江城撒花的果蔬完成签到,获得积分10
8秒前
9秒前
ddd完成签到,获得积分10
9秒前
会撒娇的梦竹完成签到 ,获得积分10
9秒前
10秒前
蓝天发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183046
求助须知:如何正确求助?哪些是违规求助? 9572370
关于积分的说明 21824411
捐赠科研通 7779694
什么是DOI,文献DOI怎么找? 3433792
关于科研通互助平台的介绍 2558024
邀请新用户注册赠送积分活动 2479971